Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism

Clinical trial NCT07091279 · RECRUITING

Trial details

NCT number: NCT07091279
Sponsor: Jeremy Veenstra-vanderweele
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Autism Spectrum Disorder Challenging Behaviour Aggression Severe Disruptive Behaviour Disorders Self-injury

Start date: 2026-01-30
Primary completion: 2028-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.